HT
Hangzhou Thinheal Pharma-Tech Co., Ltd.
CDMO · Hangzhou, China
Overview
Thinheal was founded in Hangzhou in 2019 and combines its own peptide R&D, manufacturing and sales with custom development and contract manufacturing. It offers generic therapeutic peptide APIs, including incretin and gastrointestinal peptides, plus cosmetic peptides, and reports multi-ton synthesis capacity. It holds active US Type II DMFs for Linaclotide, Semaglutide, Tirzepatide.
Capabilities
- Generic peptide APIs
- Peptide CDMO
- Custom development
- Cosmetic peptides
Quality signals
| GMP evidence | Not found |
|---|---|
| Certificates of analysis | Not found |
| Third-party testing | Not found |
| ISO certification | Not found |
| Makes own product | Yes, in-house production |